University collaboration for early detection of lung cancer


Sign up online today & collaborate

or click here to find out more

University collaboration for early detection of lung cancer

Date: 05/08/2015

The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease.

The group at Manchester, led by Professor Tony Whetton, Professor of Cancer Cell Biology and Director of the Stoller Biomarker Discovery Centre and the Manchester Precision Medicine Institute, plus Dr Phil Crosbie, Consultant in Respiratory Medicine at the Northwest Lung Centre and senior clinical lecturer at The University of Manchester, will utilise longitudinal pre-diagnosis serum samples from the UKCTOCS biobank to find markers that elevate early, before clinical presentation with symptoms.

Lung cancer is the UK’s leading cancer killer, with nearly 35,000 people dying each year from the disease. Of the 44,500 people diagnosed with lung cancer in the UK each year, only half will still be alive after six months. However, when diagnosed at its earliest stages, up to 73% of non-small cell lung cancer patients will survive for five years or more.

For more click here

Source: University of Manchester

© Catalyst Innovation Portal 2019